Literature DB >> 879490

[Influence of modern inhalation anaesthetics on haemodynamics, myocardial contractility, left ventricular volumes and myocardial oxygen supply (author's transl)].

J Tarnow, H J Eberlein, G Oser, D Patschke, E Schneider, E Schweichel, J Wilde.   

Abstract

The cardiocirculatory responses to equianaesthetic concentrations (MAC 0.5 and MAC 1.0 plus 67% N2O) of halothane, methoxyflurane, enflurane and isoflurane were studied in a total of 35 closed-chest dogs during ventilation controlled to produce normocapnia. Each anaesthetic produced a dose-related decrease in mean arterial pressure and in values reflecting cardiac function. These included cardiac output, stroke volume, left ventricular max dp/dt and ejection fraction. Isoflurane seemed slightly less depressant to the heart than the other 3 anaesthetics. Total peripheral resistance remained nearly unaffected during halothane and methoxyflurane anaesthesia but decreased significantly with MAC 1.0 enflurane and isoflurane. There was no change in heart rate at low anaesthetic concentrations. The deeper levels of anaesthesia were associated with moderate increases in heart rate. In spite of the obvious depression of myocardial contractility there was a fall in pulmonary artery and left ventricular end-diastolic pressures and in left ventricular end-diastolic volumes with each of the agents. We take this as an expression of decreased ventricular filling resulted from pooling of blood in peripheral capacitive vessels. With the exception of isoflurane, each of the other three anaesthetics reduced coronary blood flow. Coronary vascular resistance was not substantially influenced by halothane and methoxyflurane, but decreased with MAC 1.0 enflurane and isoflurane. Myocardial oxygen availability was always found to be adequate. Isoflurane even produced a significant rise in coronary venous oxygen saturation indicating coronary vasodilation. Parallel with the depression in cardiac performance and blood pressure as two of the main predictors of energy demand, myocardial oxygen consumption was found to be significantly reduced by each of the anaesthetics. The ratio of the external work of the left ventricle to its oxygen consumption indicated that myocardial efficiency deterioated. The clinical implications are discussed.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 879490

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  8 in total

1.  The comparative cardiovascular effects of sevoflurane with halothane and isoflurane.

Authors:  T Kazama; K Ikeda
Journal:  J Anesth       Date:  1988-03-01       Impact factor: 2.078

2.  Effect of halothane, enflurane and isoflurane on the end-systolic pressure-length relationship.

Authors:  A Coetzee; P Fourie; E Badenhorst
Journal:  Can J Anaesth       Date:  1987-07       Impact factor: 5.063

Review 3.  Pulmonary hypertension in children: perioperative management.

Authors:  F A Burrows; J R Klinck; M Rabinovitch; D J Bohn
Journal:  Can Anaesth Soc J       Date:  1986-09

4.  The uptake of isoflurane by the foetal lamb in utero: effect on regional blood flow.

Authors:  D R Biehl; R Yarnell; J G Wade; D Sitar
Journal:  Can Anaesth Soc J       Date:  1983-11

5.  Inhibition of the carotid chemoreceptor reflex by enflurane in chronically instrumented dogs.

Authors:  A Beck; M Zimpfer; G Raberger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1982-11       Impact factor: 3.000

6.  A comparison of postoperative recovery times between isoflurane and enflurane for pediatric dental outpatient anesthesia.

Authors:  M A Elliott
Journal:  Anesth Prog       Date:  1985 Nov-Dec

7.  Effects of sevoflurane on cardiovascular dynamics, coronary circulation and myocardial metabolism in dogs.

Authors:  S Akazawa; R Shimizu; H Kasuda; K Nemoto; Y Yoshizawa; S Inoue
Journal:  J Anesth       Date:  1988-09-01       Impact factor: 2.078

8.  Hemodynamic changes during isoflurane anesthesia.

Authors:  J S Brahim; P D Thut
Journal:  Anesth Prog       Date:  1984 Sep-Oct
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.